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Abstract
Objective:  This retrospective chart review describes the epidemiology and clinical features of 40
patients with culture-proven Mycoplasma pneumoniae infections at King Abdulaziz University
Hospital, Jeddah, Saudi Arabia.
Methods:  Patients with positive M. pneumoniae cultures from respiratory specimens from January
1997 through December 1998 were identified through the Microbiology records. Charts of
patients were reviewed.
Results:  40 patients were identified, 33 (82.5%) of whom required admission. Most infections
(92.5%) were community-acquired. The infection affected all age groups but was most common in
infants (32.5%) and pre-school children (22.5%). It occurred year-round but was most common in
the fall (35%) and spring (30%). More than three-quarters of patients (77.5%) had comorbidities.
Twenty-four isolates (60%) were associated with pneumonia, 14 (35%) with upper respiratory tract
infections, and 2 (5%) with bronchiolitis. Cough (82.5%), fever (75%), and malaise (58.8%) were the
most common symptoms, and crepitations (60%), and wheezes (40%) were the most common
signs. Most patients with pneumonia had crepitations (79.2%) but only 25% had bronchial breathing.
Immunocompromised patients were more likely than non-immunocompromised patients to
present with pneumonia (8/9 versus 16/31, P = 0.05). Of the 24 patients with pneumonia, 14
(58.3%) had uneventful recovery, 4 (16.7%) recovered following some complications, 3 (12.5%)
died because of M pneumoniae infection, and 3 (12.5%) died due to underlying comorbidities. The
3 patients who died of M pneumoniae pneumonia had other comorbidities.
Conclusion:  our results were similar to published data except for the finding that infections were
more common in infants and preschool children and that the mortality rate of pneumonia in
patients with comorbidities was high.
Introduction
Mycoplasma pneumoniae is a common cause of upper
and lower respiratory tract infections. It remains one of
the most frequent causes of atypical pneumonia particu-
larly among young adults.[1,2,3,4,5] Although it is highly
transmissible, most infections caused by this organism
are relatively minor and include pharyngitis, tracheo-
bronchitis, bronchiolitis, and croup with one fifth of in-
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fections being asymptomatic.[6,7] Only 3 -10% of
infected subjects develop symptoms consistent with
bronchopneumonia and mortality from infection is
rare.[6,7] The organism is fastidious and difficult to grow
on cultures. Therefore, diagnosis of infections caused by
this organism is usually confirmed with serological tests
or polymerase chain reaction-gene amplification tech-
niques. At King Abdulaziz University Hospital (KAUH),
Jeddah, Saudi Arabia, the facility to perform Mycoplas-
ma culture has been available since January 1997. As
published information concerning M. pneumoniae in-
fections in Saudi Arabia is scarce,[8,9,10] we wished to
study the epidemiology and clinical features of culture-
proven infections caused by this organism at this hospi-
tal.
Methods
Institution and patient population
KAUH is a tertiary care teaching hospital with a bed ca-
pacity of 265 beds and annual admissions of 18000 to
19000 patients. Patients with M. pneumoniae positive
cultures from respiratory specimens were identified over
a 24-months" period from January, 1997 through De-
cember, 1998 for this review.
Data collection
During the study period, respiratory specimens (sputum,
nasopharyngeal aspiration, endotracheal secretion, and
bronchoalveolar lavage) for M. pneumoniae culture were
obtained from patients with upper or lower respiratory
tract infections seen as inpatients or in the outpatient or
emergency departments. Respiratory specimens were
aslo Gram-stained and cultured for bacteria and viruses.
M. pneumoniae serological tests for IgG or IgM were not
available at KAUH during the study period. All positive
culture results were obtained from the Microbiology lab-
oratory records. Charts of patients were reviewed with
standardized data collection. Information collected in-
cluded patients' demographics, comorbidities, clinical
manifestations, complications, and outcome.
Microbiological methods
M. pneumoniae was cultured using the classic M. pneu-
moniae agar medium (M.P. agar) and the Pneumofast
tray (Pneumofast®, International Microbio, Signes,
France). Specimens were processed according to the in-
structions of the manufacturer. The M.P. agars and
Pneumofast trays were incubated anaerobically at 37°C
and inspected daily for 4 weeks. The organism was iden-
tified based on typical colonial morphology (granular
colonies, rarely fried-egg-like, 10-150 ∝  in diameter) on
the M.P. agar medium and the change in the Pneumofast
broth color from red to orange then to yellow (glucose
fermentation) in the absence of turbidity of the broth.
Antibiotic sensitivity profile on the Pneumofast tray was
also used for identification according to the instructions
of the manufacturer. Bacterial and viral cultures were
performed using standard methods.
Definitions
M. pneumoniae isolates were considered community-ac-
quired if they were recovered from unhospitalized pa-
tients or within 72 hours of admission to the hospital,
and nosocomial if they were recovered beyond that peri-
od.
Pneumonia was diagnosed based on clinical symptoms
and signs, along with radiographic evidence of pneumo-
nia when possible. Severe pneumonia was defined as
pneumonia associated with tachycardia (>140 /minute),
tachypnoea (>30/minute), hypotension (Systolic blood
pressure <90 mmHg), hypoxemia (arterial oxygen par-
tial pressure <8 kPa or oxygen saturation <90%), and/or
more than 2 areas of consolidation.
Outcome of patients with M. pneumoniae infection was
classified into 4 categories; uneventful recovery, recov-
ery following complications, death due to M. pneumoni-
ae infection, or death unrelated to M. pneumoniae
infection.
Data Analysis
The Statistical Package for Social Sciences (SPSS) pro-
gram was used for data analysis. Comparison of categor-
ical data was by Chi-square statistic or Fisher's exact test
for small expected values.
Results
A total of 40 respiratory specimens from 40 patients
were positive for M. pneumoniae over the 24-months
study period. The demographic and epidemiological
characteristics of the patients are summarized in Table 1.
Of all isolates, 37 (92.5%) were community-acquired and
3 (7.5%) were nosocomial. Thirty-three (82.5%) patients
required admission to the hospital and the remaining 7
(17.5%) were treated as outpatients. Twenty-four isolates
(60%) were associated with pneumonia, 14 (35%) with
upper respiratory tract infections, and 2 (5%) with bron-
chiolitis. Of the 24 cases of pneumonia, 21 were con-
firmed radiologically and the remaining 3 were
diagnosed clinically. The two cases of bronchiolitis oc-
curred in 2 children, one and three years old. Thirty-one
patients (77.5%) had comorbidities. Eleven patients
(27.5%) had cardiopulmonary comorbidities (asthma, 8,
lung fibrosis, 1, congestive heart failure, 1, congenial
heart disease, 1), 9 patients (22.5%) were immunocom-
promised (malignancy, 7, steroid therapy, 3, Human im-
munodeficiency virus infection, 1), and 11 patients
(27.5%) had other comorbidities (premature newborns,
2, and one each of myelodysplastic syndrome, myelopro-BMC Infectious Diseases (2001) 1:6 http://www.biomedcentral.com/1471-2334/1/6
liferative disorder, sickle cell anemia, Evan's syndrome,
Down syndrome, sarcoidosis, demyelinating disease,
cerebral palsy, and spinal muscle atrophy). Organisms
concomitantly isolated with M. pneumoniae from the
respiratory tract included herpes simplex virus type 1 (2
occasions), adenovirus (2 occasions), cytomegalo virus (1
occasion), respiratory syncytial virus (1 occasion), and
bacterial isolates (2 occasions: Acinetobacter species, 1,
and Enter obacter cloacae, 1).
Clinical manifestations associated with M. pneumoniae
infections are summarized in Table 2. Pneumonia was
more common than upper respiratory tract infections
(57.5 % versus 27.5%, respectively). Immunocompro-
mised patients were more likely to present with pneumo-
nia as opposed to upper respiratory tract infection or
bronchiolitis than non-immunocompromised patients
(8/9 versus 16/31, P = 0.05). Similarly, there was a ten-
dency for patients 60 years of age or older to present with
pneumonia more frequently than those below 60 (4/4
versus 20/36, P = 0.1). Of the 24 patients with clinically
or radiologically confirmed pneumonia, 19 (79.2%) had
crepitations and only 6 (25%) had bronchial breath
sounds on physical examination. Of the 16 patients in
whom wheezes were detected, 9 (56.3%) were not known
to have asthma or other obstructive airway disease.
Table 1: Epidemiological characteristics of 40 patients with M. 
pneumoniae infections.
Variable Frequency (%)
Age Groups:
0-1 year 13 (32.5)
1.1-5 year 9 (22.5)
5.1-15 year 5 (12.5)
15.1-30 year 1 (2.5)
30.1 -50 year 5 (12.5)
50.1 -70 year 5 (12.5)
>70 year 2 (5.0)
Gender:
Male 24 (60)
Female 16 (40)
Nationality:
Saudi 23 (57.5)
Non-Saudi 17 (42.5)
Season:
Summer 4(10)
Fall 14 (35)
Winter 10 (25)
Spring 12 (30)
Community-acquired / Hospital-acquired 37 (92.5) / 3 (7.5)
Patients with comorbidities 31 (77.5)
Table 2: Clinical manifestations of culture-proven M. pneumoniae 
infections in 40 patients.
Variable Frequency (%)
Type of infection:
Pneumonia 24 (60)
Upper respiratory tract infection 14 (35)
Bronchiolitis 2(5)
Fever: 30 (75)
Low grade (37.2-38°C) 16 (40)
Moderate grade (38.1-39°C) 12 (30)
High grade (>39°C) 2(5)
Chills 3 (7.5)
Malaise 20/34 (58.8)
Pleuritic chest pain 3 (7.5)
Cough:
Absent 11(27.5)
Mild 18(45)
Moderate 8(20)
Severe 3 (7.5)
Sputum production1
No sputum (dry cough) 11(37.9)
Mild 12(41.4)
Moderate 2 (6.9)
Copious 0
Unknown (babies) 4(13.8)
Color of sputum:2
White 11(78.6)
Yellow 3 (21.4)
Bronchial breathing3 6(25)
Crepitations 24 (60)
Wheezes 16 (40)
Pleural effusion 3 (7.5)
Abnormal chest x-ray 21 (52.5)
Pattern of chest x-ray abnormalities:4
Localized infiltrate(s) 11(52.4)
1 area 5 (23.8)
2 areas 4(19)
3 or more areas 2 (9.5)
Bronchopneumonia 5 (23.8)
Bronchiolitis 1 (4.8)
Interstitial infiltrate 2 (9.5)
ARDS5 3 (14.3)
1 For 29 patients with cough. 2 For 14 patients with productive cough. 
3 For 24 patients with pneumonia. 4 For 21 patients with radiologically-
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Complications and outcome of patients are shown in Ta-
ble 3. Of the 24 patients with pneumonia, 21 (87.5%)
were admitted to the hospital, and 20 (83.3%) had co-
morbidities. All patients with upper respiratory tract in-
fections (11 patients) or bronchiolitis (2 patients) had
uneventful recovery. Of the 24 patients with pneumonia,
14 (58.3%) had uneventful recovery, 4 (16.7%) recovered
following some complications (acute respiratory distress
syndrome, 2, respiratory failure, 1, septic shock, 1), 3
(12.5%) died because of M pneumoniae infection, and 3
(12.5%) died due to underlying comorbidities. The 3 pa-
tients who died of M pneumoniae pneumonia had other
comorbidities; one had congestive heart failure, the sec-
ond had congenital heart disease, and the third was a 3-
months old infant born prematurely at 32 weeks of ges-
tation who previously had 3 episodes of pneumonia due
to other pathogens.
Discussion
Mycoplasma pneumoniae is one of the most common
causes of atypical pneumonia accounting for 5-23% of
community-acquired pneumonia,[1,2,3,4,5] In a study of
511 children with acute respiratory tract infection in Riy-
adh, Saudi Arabia, Mycoplasma pneumoniae was found
to be the second most common causative agent after Res-
piratory syncytial virus (RSV) accounting for 9% of all
cases,[8] In a study of 112 adult patients with community
acquired pneumonia admitted to a military hospital in
Riyadh, Saudi Arabia, this organism accounted for 6% of
all cases,[9] In another retrospective study of 567 pneu-
monic episodes in adult patients from Al-Qassim area,
the organism accounted for 23% of all episodes,[10] The
organism also causes other relatively minor infections
such as pharyngitis, tracheobronchitis, bronchiolitis,
and croup. It is transmitted from person-to-person by in-
fected respiratory droplets during close contact. It is
most common in school-aged children, military recruits,
and college students.[11] Most cases occur singly or as
family outbreaks. Larger outbreaks can also occur in
closed populations such as military recruit camps or
boarding schools,[12] Infection occurs most frequently
during the fall and winter in temperate climates but may
develop year-round,[13] The average incubation period
is 3 weeks following exposure,[6] Although rare, compli-
cations are protean and may involve virtually any organ
system such as the respiratory system (e.g.: pleurisy,
pneumothorax, acute respiratory distress syndrome,
lung abscess), the hematologic system (e.g.: hemolytic
anemia, intravascular coagulation, thrombocytopenia),
the dermatologic system (e.g.: maculopapular or urticar-
ial rashes, erythema multiforme, erythema nodosum),
the musculoskeletal system (e.g.: myalgias, arthralgias,
arthritis), the cardiovascular system (e.g.: pericarditis,
myocarditis), the nervous system (e.g.: meningoen-
cephalitis, Guillain-Barre syndrome, neuropathies, acute
psychosis), or the eye (optic disc edema, optic nerve atro-
phy, retinal exudation and hemorrhag-
es).[6,7,14,15,16,17,18] Immunity following infection is
not long lasting.[11]
In our study, the infection affected all age groups but was
most common in infants (32.5%) and preschool children
(22.5%), and least common in adults aged 15 to 30 years
(2.5%) and elderly above 70 years of age (5%). This con-
trasts with data from temperate countries where the in-
fection is most common in school-aged children, and
young adults.[11] One possible explanation for this dif-
ference is that infants and preschool children perhaps
had more severe infections than did school-aged chil-
dren, and young adults which prompted presentation of
the former group to the hospital. The infection occurred
year-round but was most common in the fall (35%), and
spring (30%), and least common in the summer (10%).
Most infections were community-acquired (92.5%).
More than one half of patients (57.5%) presented with
pneumonia, and about a third (27.5%) presented with
upper respiratory tract infection, Immunocompromised
patients and patients 60 years of age or older were more
likely to present with pneumonia as opposed to upper
respiratory tract infection than non-immunocompro-
mised patients or those below 60 years of age. Cough
(82.5%), fever (75%), and malaise (58.8%) were the most
common presenting symptoms. Cough was usually dry
or slightly productive of white sputum and mild to mod-
erate in severity. Most febrile patients had mild to mod-
Table 3: Complications and outcome of M. pneumoniae infections 
in 40 patients.
Variable Frequency (%)
Complications:
Severe pneumonia1 14 (35)
Hypotension 3 (7.5)
Respiratory failure requiring ventilation 8(20)
ARDS2 4(10)
Hemolysis 2(5)
Rash 1 (2.5)
Neurological complications 0
Outcome:
Uneventful recovery 30 (75)
Recovery following complications3 4(10)
Death due to M. pneumoniae 3 (7.5)
Death due to other causes 3 (7.5)
1 See definition of severe pneumonia in text. 2 ARDS=Acute respirato-
ry distress syndrome. 3 Respiratory failure, septic shock, acute respira-
tory distress syndrome.BMC Infectious Diseases (2001) 1:6 http://www.biomedcentral.com/1471-2334/1/6
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erate fever of 39°C or less; high-grade fever of more than
39°C was rare. Crepitations (60%), and wheezes (40%)
were the most common signs. Wheezes were as common
in patients with no history of obstructive airway disease
(9 patients) as it was in those with such a history (7 pa-
tients). Bronchial breathing as a sign of consolidation
was detected in only one fourth of patients with pneumo-
nia, which is consistent with the known disparity be-
tween clinical and radiological signs of M pneumoniae
pneumonia. Crepitations, however, were detected in the
majority (79.2%) of patients. Pleuritic chest pain and
pleural effusion were rare.
More than half (56.5%) of the patients with pneumonia
had uneventful recovery. Mortality from M. pneumoniae
pneumonia was high (12.5%) and occurred only in pa-
tients with underlying comorbidities. None of the 9 pa-
tients with no underlying comorbidities died of M
pneumoniae pneumonia. The relatively high complica-
tions rate (16.7%) and mortality (12.5%) related to M.
pneumoniae pneumonia are likely due to selection bias
as most patients with pneumonia were sick enough to re-
quire admission to the hospital (21/24 or 87.5%) and
most of them had comorbidities (20/24 or 83.3%).
In conclusion, our data shed some light on the epidemi-
ology and clinical features of M pneumoniae infections
in one of the Saudi tertiary care centers. The data are
comparable to those of other countries except for the
finding that infections were more common in infants and
preschool children than in school children and young
adults. Additionally, mortality attributable to M. pneu-
moniae pneumonia was relatively high in patients with
comorbidities. It is hoped this information will assist cli-
nicians in their approach and management of respiratory
tract infections.
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